Kang‐Ju Chou

Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

Brad H. Rovin, Jonathan Barratt, Hiddo J.L. Heerspink et al. · The Lancet · 2023 · 224 citations · Full text

Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

Hiddo J.L. Heerspink, Jai Radhakrishnan, Charles E. Alpers et al. · The Lancet · 2023 · 203 citations · Full text

Glomerulonephritis, Active-controlled Clinical Trial, Renal Function +9

Physiological changes during hemodialysis in patients with intradialysis hypertension

Kang‐Ju Chou, P.-T. Lee, Chien‐Liang Chen et al. · Kidney International · 2006 · 139 citations

Hemodialysis, Hypertension, Renal Disease +8

Acute Oxalate Nephropathy After Ingestion of Star Fruit

Chien‐Liang Chen, Hua-Chang Fang, Kang‐Ju Chou et al. · American Journal of Kidney Diseases · 2001 · 134 citations

Urology, Medicine, Star Fruit +6

Acute oxalate nephropathy induced by star fruit in rats

Hua-Chang Fang, Chien‐Liang Chen, Jyh‐Seng Wang et al. · American Journal of Kidney Diseases · 2001 · 38 citations

Medicine, Star Fruit, Physiology +6